ERBB2 and breast carcinoma: Current breast cancer classification defines the luminal hormone receptor positive (HR+), HER2-enriched (HER2-E) (HR−/HER2 overexpressing), and the triple negative (TNBC) (ER−/PR−/HER2−) groups, as the main basic subtypes32,33.